National and Kapodistrian University of Athens
Κυτταρογενετική, μοριακή και επιγενετική διερεύνηση της οξείας μυελογενούς λευχαιμίας
Abstract
dc:descriptionOver the last few decades, AML research has focused on genetic and epigenetic hanges, which appear to be involved in the development and progression of the disease. These molecular alterations can affect response to treatment and overall persistence, but also serve as predictors or therapeutic targets for new targeted therapies.The purpose of this PhD thesis is:•The identification of the ASXL1 gene mutations, the investigation of their contribution to the development of AML and their correlation with cytogenetic, demographic (age and gender) and clinical properties of patients.•The identification of RAD21 promoter methylation in AML patients and its correlation with specific chromosomal alterations. More specifically, RAD21 gene promoter methylation is studied in patients with AML as a possible mechanism for silencing of the RAD21 gene expression which may contribute to the development of AML. The presence of a methylated or non-methylated promoter of RAD21 also correlates with the demographic characteristics of patients and their specific chromosomal alterations.In the framework of this PhD dissertation, bone marrow samples of 360 adult patients with primary and / or secondary AML from all hospitals in the country and bone marrow samples of 10 healthy non-relatives of Greek origin of respective age and sex were taken.The detection of mutations in exon 12 of the ASXL1 gene was performed by using the Sanger sequencing method. The study of methylation of the RAD21 gene promoter was performed with Qiagen's Epitech methyl II restriction kit. The analysis was performed in patients with primary and secondary AML. More precisely, 60 bone marrow samples of adult patients with AML were studied, of which 42 had primary AML and 18 secondary AML. The results of this PhD thesis highlight the contribution of the ASXL1 and RAD21 genes to the pathogenesis of AML and the presence of specific chromosomal alterations. The results of this PhD are expected to contribute to the understanding of leukemogenesis’ mechanisms in as well as to the design of appropriate personalized therapeutic protocols depending on acquired genetic and epigenetic lesions of patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kakosaiou, Aikaterini
- Κακοσαίου, Αικατερίνη
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45568